Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding compared with those taking metoprolol, according to a new study from Vanderbilt Health researchers and colleagues at the Perelman School of Medicine.
Continue Reading this article here
